#MELCSM
LightNews LightNews
onclive.bsky.social
Novel STAT3 Inhibitor TT1-101 Is Safe and Shows Antitumor Activity in R/R HCC and Other Solid Tumors #gyncsm #melcsm #lcsm #oncology
www.onclive.com/view/novel-s...
Novel STAT3 Inhibitor TT1-101 Is Safe and Shows Antitumor Activity in R/R HCC and Other Solid Tumors
The STAT3 inhibitor TT1-101 generated confirmed partial responses among patients with relapsed/refractory HCC and other solid tumors.
www.onclive.com
May 9, 2025 at 2:07 PM
moloncology.bsky.social
The IFNγ-CIITA-MHC II axis modulates melanoma cell susceptibility to NK-cell-mediated cytotoxicity

👉 buff.ly/tJzVEhb

#Melanoma #MELCSM #ImmunoOnc
November 6, 2025 at 9:30 AM
oncologynurseadv.bsky.social
The use of rule out #melanoma terminology on pathology requisitions has a low positive predictive value for the diagnosis of melanoma. Published in @dermatologyadvisor.bsky.social.

https://bit.ly/4oHtCRr

#melcsm #skcsm
Rule Out Melanoma Terminology on Pathology Requisitions Has Low Predictive Value - Oncology Nurse Advisor
Researchers studied the diagnostic yield associated with rule of melanoma terminology used on skin biopsy requisition forms.
bit.ly
November 1, 2025 at 8:46 PM